Differential Expression and Analysis of Extrachromosomal Circular DNAs As Serum Biomarkers in Pulmonary Arterial Hypertension

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2024 Apr 25

PMID 38664836

Authors

Chun Zhang

Qiang Du

Xiao Zhou

Tianyu Qu

Yingying Liu

Kai Ma

Ziling Shen

Qun Wang

Zaikui Zhang

Ruifeng Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Extrachromosomal circular DNAs (eccDNAs) have been reported to play a key role in the occurrence and development of various diseases. However, the characterization and role of eccDNAs in pulmonary arterial hypertension (PAH) remain unclear.

Methods: In the discovery cohort, we first explored eccDNA expression profiles by Circle-sequencing analysis. The candidate eccDNAs were validated by routine polymerase chain reaction (PCR), TOPO-TA cloning and Sanger sequencing. In the validation cohort, 30 patients with PAH and 10 healthy controls were recruited for qPCR amplification to detect the candidate eccDNAs. Datas at the baseline were collected, including clinical background, biochemical variables, echocardiography and hemodynamic factors. Receiver operating characteristic curve was used to investigate the diagnostic effect of the eccDNA.

Results: We identified a total of 21,741 eccDNAs in plasma samples of 3 IPAH patients and 3 individuals in good health, and the expression frequency, GC content, length distribution, and genome distribution of the eccDNAs were thoroughly characterized and analyzed. In the validation cohort, 687 eccDNAs were differentially expressed in patients with IPAH compared with healthy controls (screening threshold: |FC|≥2 and P < 0.05). Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the specific eccDNAs in IPAH were significantly enriched in calcium channel activity, the mitogen-activated protein kinase pathway, and the wnt signaling pathway. Verification queue found that the expression of eccDNA-chr2:131208878-131,424,362 in PAH was considerably higher than that in healthy controls and exhibited a high level of accuracy in predicting PAH with a sensitivity of 86.67% and a specificity of 90%. Furthermore, correlation analysis disclosed a significant association between serum eccDNA-chr2:131208878-131,424,362 and mean pulmonary artery pressure (mPAP) (r = 0.396, P = 0.03), 6 min walking distance (6MWD) (r = -0.399, P = 0.029), N-terminal pro-B-type natriuretic peptide (NT-proBNP) (r = 0.685, P < 0.001) and cardiac index (CI) (r = - 0.419, P = 0.021).

Conclusions: This is the first study to identify and characterize eccDNAs in patients with PAH. We revealed that serum eccDNA-chr2:131208878-131,424,362 is significantly overexpressed and can be used in the diagnosis of PAH, indicating its potential as a novel non-invasive biomarker.

References

Wang Y, Wang M, Djekidel M, Chen H, Liu D, Alt F . eccDNAs are apoptotic products with high innate immunostimulatory activity. Nature. 2021; 599(7884):308-314. PMC: 9295135. DOI: 10.1038/s41586-021-04009-w. View

Liao Z, Jiang W, Ye L, Li T, Yu X, Liu L . Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression. Biochim Biophys Acta Rev Cancer. 2020; 1874(1):188392. DOI: 10.1016/j.bbcan.2020.188392. View

Yan Y, Guo G, Huang J, Gao M, Zhu Q, Zeng S . Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance. J Hematol Oncol. 2020; 13(1):124. PMC: 7491193. DOI: 10.1186/s13045-020-00960-9. View

Moller H, Parsons L, Jorgensen T, Botstein D, Regenberg B . Extrachromosomal circular DNA is common in yeast. Proc Natl Acad Sci U S A. 2015; 112(24):E3114-22. PMC: 4475933. DOI: 10.1073/pnas.1508825112. View

Paulsen T, Shibata Y, Kumar P, Dillon L, Dutta A . Small extrachromosomal circular DNAs, microDNA, produce short regulatory RNAs that suppress gene expression independent of canonical promoters. Nucleic Acids Res. 2019; 47(9):4586-4596. PMC: 6511871. DOI: 10.1093/nar/gkz155. View

Zhao Y, Yu L, Zhang S, Su X, Zhou X . Extrachromosomal circular DNA: Current status and future prospects. Elife. 2022; 11. PMC: 9578701. DOI: 10.7554/eLife.81412. View

Poch D, Mandel J . Pulmonary Hypertension. Ann Intern Med. 2021; 174(4):ITC49-ITC64. DOI: 10.7326/AITC202104200. View

Koche R, Rodriguez-Fos E, Helmsauer K, Burkert M, MacArthur I, Maag J . Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma. Nat Genet. 2019; 52(1):29-34. PMC: 7008131. DOI: 10.1038/s41588-019-0547-z. View

Cohen S, Houben A, Segal D . Extrachromosomal circular DNA derived from tandemly repeated genomic sequences in plants. Plant J. 2007; 53(6):1027-34. DOI: 10.1111/j.1365-313X.2007.03394.x. View

10.

Moller H, Mohiyuddin M, Prada-Luengo I, Sailani M, Halling J, Plomgaard P . Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. Nat Commun. 2018; 9(1):1069. PMC: 5852086. DOI: 10.1038/s41467-018-03369-8. View

11.

Noer J, Horsdal O, Xiang X, Luo Y, Regenberg B . Extrachromosomal circular DNA in cancer: history, current knowledge, and methods. Trends Genet. 2022; 38(7):766-781. DOI: 10.1016/j.tig.2022.02.007. View

12.

Yan L, Huang Z, Zhao Z, Zhao Q, Tang Y, Zhang Y . The Prognostic Impact of Serum Uric Acid on Disease Severity and 5-Year Mortality in Patients With Idiopathic Pulmonary Artery Hypertension. Front Med (Lausanne). 2022; 9:805415. PMC: 8825367. DOI: 10.3389/fmed.2022.805415. View

13.

Wang M, Chen X, Yu F, Ding H, Zhang Y, Wang K . Extrachromosomal Circular DNAs: Origin, formation and emerging function in Cancer. Int J Biol Sci. 2021; 17(4):1010-1025. PMC: 8040306. DOI: 10.7150/ijbs.54614. View

14.

Hoeper M, Boucly A, Sitbon O . Age, risk and outcomes in idiopathic pulmonary arterial hypertension. Eur Respir J. 2018; 51(5). DOI: 10.1183/13993003.00629-2018. View

15.

Jiang X, Pan X, Li W, Han P, Yu J, Li J . Genome-wide characterization of extrachromosomal circular DNA in gastric cancer and its potential role in carcinogenesis and cancer progression. Cell Mol Life Sci. 2023; 80(7):191. PMC: 10300174. DOI: 10.1007/s00018-023-04838-0. View

16.

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

17.

Zuo S, Li X, Yang Y, Zhou J, He Q . A Quick Method to Synthesize Extrachromosomal Circular DNA In Vitro. Molecules. 2023; 28(10). PMC: 10220718. DOI: 10.3390/molecules28104236. View

18.

Zou S, Chen S, Rao G, Zhang G, Ma M, Peng B . Extrachromosomal circular MiR-17-92 amplicon promotes HCC. Hepatology. 2023; 79(1):79-95. DOI: 10.1097/HEP.0000000000000435. View

19.

Guo M, Zhang M, Cao X, Fang X, Li K, Qin L . Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. Respir Res. 2022; 23(1):6. PMC: 8753901. DOI: 10.1186/s12931-022-01927-9. View

20.

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View